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t 2  Abbreviations: 
QoL: Quality of life 
PedsQL: Pediatric Quality of Life inventory  
BMI: Body mass index  
PHN: Pediatric Heart Network 
NYHA: New York Heart Association  
BNP: B-type natriuretic peptide 
HLHS: Hypoplastic left heart syndrome 
NHANES: National Health and Nutrition Examination Survey  
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Introduction: We sought to evaluate the prevalence of delayed puberty and abnormal anthropometry and 
its association with quality of life (QoL) in young Fontan survivors. 
Methods: Th s was a cross-sectional study at 11 Pediatric Heart Network centers. Demographic and 
clinical data, anthropomety and Tanner stage were collected. Anthropometric measurements and pubertal 
stage were compared to United States norms. QoL was assessed using Pediatric Quality of Life inventory 
(PedsQL). Mixed effects regression modeling adjusting for clustering by center was used to evaluate 
factors associated with abnormal anthropometry and delayed puberty, and associations with QoL. 
Results: Of the 299 subjects, 42% were female. Median enrollment age was 13.9 years and median age 
at Fontan was 3 years. Fontan survivors had a higher prevalence of short stature relative to normative 
data (20% vs. 5%, p<0.0001) and an increased prevalence of abnormal BMI (16% vs. 10%, p<0.0001) 
[low (43%) and high (57%)]. Fontan subjects, both males (58%) and females (58%) had a delay of 1.5- 2 
years in ≥1 Tanner stage parameter compared to normal population. There was no association between 
delayed puberty and QoL. Abnormal anthropometry was associated with lower overall (62.3.±17.3 vs. 
72.5 ±16.6; p <0.001) and physical appearance scores (72.2 ±27.4 vs. 79.8±21.5; p<0.01). Lower 
exercise capacity was associated with abnormal anthropometry and >2 surgeries before Fontan was 
associated with delayed puberty. Lower family income (<$25,000) and hypoplastic left heart syndrome 
were associated with lower QoL. 
Conclusion: Compared to the normal population, Fontan survivors have high prevalence of short stature, 
abnormal BMI and delayed puberty. Abnormal anthropometry, but not delayed puberty, was associated 
with lower overall QoL and perceived physical appearance scores. Routine screening for abnormal 
anthropometry, especially in HLHS and in lower socioeconomic status families, should be considered to 
allow for interventions which might ameliorate the negative psychosocial impact.  
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Growth failure in infants and children with congenital heart disease, particularly in infants with single 
ventricle physiology, is a well-known phenomenon.
1-3
  Patients with single ventricle physiology are a 
heterogeneous group who typically undergo a series of high-risk palliative cardiac surgeries culminating 
in the Fontan operation. Fontan physiology is inherently associated with a lifelong risk of multiple medical 
complications including ventricular dysfunction, arrhythmias, stroke, exercise intolerance, protein-losing 
enteropathy, plastic bronchitis, liver dysfunction and premature death.
4-6
 These complications may 
predispose them at high risk for growth and pubertal aberrations. Abnormalities in height and weight have 
been reported in Fontan survivors
7
  and abnormal anthropometry has been associated with lower 
functional health status scores. 
7
Previous studies demonstrated long-term growth and cognitive 
aberrations secondary to growth failure in early life including higher prevalence of short stature, poor 
school performance, and higher incidence of behavioral and attention issues.
8
 The same factors that 
predispose single ventricle patients to abnormal anthropometry have also been implicated in the delayed 
puberty. However, despite the high prevalence of these risk factors, the actual prevalence of delayed 
puberty in Fontan survivors is unknown. Furthermore, the effects of delayed puberty on quality of life 
(QoL) have not been studied in Fontan survivors. 
We sought to determine the prevalence of abnormal anthropometry and delayed puberty in adolescent 
Fontan survivors and to define demographic and clinical factors associated with these abnormalities. We 
also explored the association between abnormal anthropometry and delayed puberty and QoL. We 
hypothesized that the prevalence of abnormal anthropometry and delayed puberty would be significantly 
higher in the study population compared to the normal population and these abnormalities would be 
associated with lower QoL scores. 
Methods 
This study was supported by a grant from the National Heart, Lung, and Blood Institute funded Pediatric 
Heart Network (PHN). The authors are solely responsible for the design and conduct of this study. All 
study analyses, the drafting and editing of the paper and its final contents were approved by all the 
authors.  
Page 4 of 21
Congenital Heart Disease
Congenital Heart Disease
This article is protected by copyright. All rights reserved.
A
ut
ho
r M
an
us
cr
ip
t 5  Study Population 
This was a cross-sectional multicenter study of adolescent Fontan survivors between the ages of 8 and 
18 years. All Fontan patients between the ages of 8 and 18 years who consented or whose 
parent/guardian consented to participate in the study from 11 PHN centers (02/2013-03/2015) were 
eligible to participate in the study. Patients or their parent/guardian who could not understand the QoL 
English forms were excluded. Patients with genetic syndrome were specifically excluded from the study. 
The study was approved by the Institutional Review Boards at all participating centers. 
Tanner staging: Participants Tanner stage was determined by using a self-assessment pictorial Tanner 
stage questionnaire. Study subjects were given a previously validated standardized series of realistic 
color images with explanatory text to assess their own pubertal development
9, 10
. Compared with Tanner’s 
original black and white pictures, self-assessment of the pubertal stage by using realistic color images is  
strongly associated with a clinician’s objective assessment of Tanner stage
9
. Self-reported age of 
menarche was also recorded. 
Definitions 
Abnormal anthropometry: Abnormal anthropometry was defined as presence of either short stature or 
abnormal BMI. Short stature was defined as height <5th percentile based on the CDC growth curves
11
. 
Abnormal BMI was defined as BMI <5th percentile or ≥ 95th percentile based on the NHANES III data.  
Delayed puberty: Delayed puberty was clinically defined as failure to reach a Tanner stage at an age 
that is 2 standard deviation greater than the population mean for that specific Tanner stage obtained from 
the NHANES III data. 
12, 13
 
Quality of Life (QoL): QoL was assessed using a previously validated Pediatric Quality of Life Inventory 
(PedsQL) and Cardiac Module. We chose to use PedsQL for this study because it is shorter, easier to 
complete compared to other instruments and provides both the child’s and the parent’s perspectives 
across the entire study age range. 
14
PedsQL was also a preferred instrument for QoL testing because its 
generic core scale has been obtained from a large normative database of ethnically diverse healthy 
children as well as children with chronic health conditions. 
14
The 23-item PedsQL generic core scales 
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and school functioning (5 items). The PedsQL 3.0 cardiac module has 5 scales related to symptoms, 
perceived physical appearance, treatment anxiety, cognitive problems, and communication for parent 
proxy report and children aged 8 to 18 years. 
Socioeconomic status: Socioeconomic status was assessed using a parent-completed form that 
collected information regarding family income, race and ethnicity, education of the primary caregiver, 
family marital status and employment of the primary caregiver. 
Normative data: Normative data for height were obtained from CDC growth curves.  Normative data for 
BMI and Tanner stages were obtained from National Health and Nutrition Examination Survey (NHANES 
III). The NHANES surveys were designed to give national normative estimates of the health and 
nutritional status of the U.S. civilian, non-institutionalized population. NHANES III was conducted from 
1988 through 1994 using a stratified, multistage probability design. 
The medical record was reviewed for demographics, cardiac anatomic diagnosis, type of surgical 
palliation, details of Fontan and other surgical palliation including the timing, presence of ventricular 
dysfunction and atrioventricular valve regurgitation, medications, exercise stress test results, New York 
Heart Association (NYHA) Functional Classification and B-natriuretic peptide measurements (BNP). All 
data included in the study were collected within 6 months of study participation. 
Statistical analysis 
Continuous variables are described as mean ± standard deviation or median (inter-quartile range). BMI 
and short stature were treated as categorical variables, based on the definition above. To evaluate the 
differences between subjects with abnormal measures (BMI and height) from the normal population, one-
sample z-test was performed. For each of the Tanner stages, inverse variance weighting method to pool 
mean age difference across strata was used and then Z test was used to examine the statistical 
significance for the overall effect. Comparisons between self-reported and parent reports (proxy report) 
mean generic and domain scores and cardiac module domain score were performed using a paired T-test 
and Lin Index for concordance correlation coefficient. A mixed effects regression model adjusting for 
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factors and abnormal anthropometry and delayed puberty. A backwards elimination method was used for 
variable selection before performing the logistic regression. Similarly, to study the associations between 
delayed puberty and abnormal anthropometry and QoL, a mixed effects regression model adjusting for 
clustering by center was performed. In studies with multiple centers, we sometimes expect patient 
outcomes to differ according to center. This could be due to differences between patients who present to 
different centers, or because of differences between the centers themselves. To minimize the impact of 
any between-center differences on the study results, adjustment for clustering is performed to account for 
center-effects in the analysis model.  This mixed effect model included basic demographic variables, 
family income, race, ethnicity, education of the primary caregiver, family marital status, and employment 
of the primary caregiver. All analyses were conducted using SAS version 9.4 (SAS Institute, Inc., Cary, 
NC).  
Results  
Of the 299 subjects enrolled in the study, 33% had hypoplastic left heart syndrome (HLHS). The median 
age of the study cohort was 13.9 years (IQR: 11.3, 16.1 years). Baseline characteristics of the study 
population are shown in Table 1. 
Abnormal anthropometry 
BMI: Compared to a 10% prevalence of abnormal BMI in the normal US population, 16% of adolescent 
Fontan survivors had abnormal BMI (p<0.0001). Of the Fontan survivors who had an abnormal BMI, 43% 
had BMI <5
th
 percentile and 57% had BMI >95
th
 percentile.  
Short Stature: The prevalence of short stature in adolescent Fontan survivors was higher relative to the 
normal population. In the study cohort, 20% of participants had short stature compared to 5% in the 
normal population (P< 0.0001). 
Delayed Puberty: More than half of the study population (males: 58%, females: 58%) had delay in at 
least one Tanner stage parameter. Pubic hair growth was delayed in 43% of males and 47% of females. 
Genitalia development was delayed in 54% of males and breast development was delayed in 47% of 
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and 36% of females. On average, both in male and female Fontan survivors, there was a delay of 1.5-2 
years in achievement of Tanner stages compared to the normal population (Figure 1).  
QoL: There was moderate agreement between self-reported and proxy (parent reported) QoL scores 
(Figure 2). However, parent QoL scores were lower than the child/adolescent’s scores (68.9 vs.72.6; 
p<0.01) for the majority of domains in generic core scale and cardiac module. In Fontan survivors, 
abnormal anthropometry was associated with lower QoL (generic core scale total score: 62.3. ±17 vs.72.5 
±16.6; p <0.001) (Figure 2A and 2B) and lower cardiac module perceived physical appearance scores on 
proxy report (72.2 ±27.4 vs.79.8±21.5; p<0.01) (Figure 2D). Delayed puberty was not associated with 
lower QoL (generic core scale total score: 68.3 ±17.4 vs.70±17.5; p= 0.4) (Figure 2C).  
Factors associated with abnormal anthropometry and delayed puberty: NYHA Class III and IV and 
lower oxygen consumption on exercise stress test were independently associated with higher risk of 
abnormal anthropometry (Table 2). More than two cardiac surgeries before Fontan procedure was the 
only factor associated with higher risk of delayed puberty. Importantly, ventricle morphology, weight-for-
age z-score, age at any surgical palliation procedure, cardiac diagnoses, atrioventricular valve 
regurgitation, use of digoxin therapy, use of pulmonary vasodilator therapy, BNP level, and number of 
Fontan complications were not associated with either abnormal anthropometry or delayed puberty. 
Association between abnormal anthropometry and delayed puberty and QoL: On multivariable 
mixed effects modeling controlling for clustering among centers, delayed puberty was not associated with 
lower QoL. Factors independently associated with lower overall QoL score were abnormal anthropometry, 
family income <$25000, and HLHS. Female sex and lower family income were independently associated 
with lower perceived physical appearance scores (Table 2). 
Discussion 
This is the first study to evaluate the prevalence of delayed puberty and its impact on QoL in young 
Fontan survivors. More than half of the Fontan survivors had delay in one of the Tanner stage parameters 
and in both sexes, there was a delay of 1.5-2 years between Fontan survivors and the normal population 
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children with Fontan than in healthy controls, it was not associated with lower overall QOL. Instead, 
abnormal anthropometry was associated with lower overall QOL and perceived physical appearance 
scores. 
Delayed puberty 
Many chronic diseases are known to be associated with delayed puberty.
15
 In chronic diseases, delayed 
puberty is usually accompanied by a delay in physical growth and the pubertal growth spurt.
15
 The 
etiology of delayed puberty in Fontan survivors is likely to be multifactorial and may include chronic low 
cardiac output state and cyanosis, multiple cardiopulmonary bypass, endocrine abnormalities and Fontan 
associated complications like Fontan associated liver disease and protein losing enteropthy.
4-6
 More than 
two cardiac surgeries before Fontan palliation was the only factor independently associated with delayed 
puberty in this study. We speculate that multiple cardiopulmonary bypass surgeries early in childhood 
may result in hypothalamic-pituitary gonadal axis malfunction. Although cardiopulmonary bypass 
associated hypothalamic-pituitary-adrenal axis malfunction is a known phenomenon, the effects of 
cardiac bypass surgery on gonadal function has not been evaluated.
16
 Future studies should evaluate the 
effects of multiple cardiopulmonary bypass surgeries on adolescent gonadal function and integrity of 
hypothalamic-pituitary-adrenal axis. 
 In this study we did not find an association between delayed puberty and QoL scores. A possible 
explanation for this finding is that Fontan survivors have significantly lower QoL compared to peers 
secondary to a multitude of health issues and delayed puberty may not be perceived by them as a 
significant concern. An alternate explanation for the lack of association between delayed puberty and QoL 
may be secondary to the fact that even though the onset of puberty was delayed, older participants 
achieved complete pubertal development (Tanner stage 5).  Since delayed puberty was not associated 
with worse QoL scores in Fontan survivors, the rational for evaluation and management of delayed 
puberty and hypogonadism in this population may be improving fertility and bone mineralization and 
achievement of height potential. Although, at present, majority of women with Fontan are advised against 
pregnancy, with improvement in their management could change this recommendation in the future. 
Page 9 of 21
Congenital Heart Disease
Congenital Heart Disease
This article is protected by copyright. All rights reserved.
A
ut
ho
r M
an
us
cr
ip
t 10  Abnormal anthropometry 
Short stature: Compared to the normal population, Fontan survivors have a 4-fold increase in the 
prevalence of short stature and nearly 2-fold higher abnormality in their BMI. These findings are similar to 
previous reports of abnormal BMI and short stature in Fontan survivors.
7, 17, 18
 Short stature was seen in 
20% of young Fontan survivors in this study which is similar to previous report of a quarter of young 
Fontan survivors with short stature.
7
 Similar to the possible etiologies for delayed puberty, short stature in 
Fontan patients may be secondary to the multisystem abnormalities. In other chronic diseases, a slowing 
of growth velocity and a delayed pubertal growth spurt observed in early adolescence may lead to short 
adult height.
15, 19
  
Abnormal BMI: Similar to findings of this study increased prevalence of abnormal BMI  in Fontan patients 
has been reported previously.
17, 18
 The abnormal BMI were almost equally split between low BMI (43%) 
and high BMI (57%). Not surprisingly, reduced exercise performance (NYHA grade 3 and 4 and lower 
maximal oxygen uptake) was associated with abnormal anthropometry. This finding suggests a possible 
role of reduced cardiac output state as an etiology for anthropometric abnormalities in Fontan patients. It 
is widely believed that short children can suffer from physical, social, and psychological problems. 
20, 21
 
Our findings are similar to those reported by previous studies in that the Fontan survivors with shorter 
stature and high BMI have poorer functional heath status.
17
 We also noted that abnormal anthropometry 
was associated with lower self-reported QoL. Association of abnormal anthropometry with lower parent 
reported physical appearance domain score (cardiac module) but not with self-reported score is an 
interesting and new finding and further points to the differences in health perceptions between children 
and their parents.   
It’s not surprising that Fontan survivors in this study have significantly lower QoL compared to their 
peers.
5, 13, 22-24
 Multiple prior reports have shown reduced QoL in patients with significant congenital heart 
diseases including patients with single ventricle physiology and Fontan. 
23
Our study finding of worse 
parent’s perceptions of QoL status of their children compared to the children’s perceptions after the 
Fontan procedure has been reported before. 
24
  Lower family income was associated with lower health-
related QoL in Fontan survivors. In fact a family income of < $25,000 was associated with a greater 
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between income and health-related quality of life (QoL).
25
 In this study HLHS was associated with lower 
QoL compared to non-HLHS patients and this could be related to the higher mortality and morbidity 
associated with HLHS. This finding is in contrast to a previous study that reported no difference in QoL 
between HLHS and non-HLHS Fontan survivors.
22
 
Limitations: There is potentially a selection bias with a healthier population of Fontan survivors more likely 
consenting to study participation. However, the prevalence of Fontan associated complications in this 
study cohort is similar to contemporary reports indicates that the study population is a representative 
sample of the contemporary Fontan cohort. The consent rate at most centers were more than 90% 
minimizing the selection bias. The study population was primarily Caucasian and generalizability of 
pubertal findings that are influenced by race/ethnicities to other groups is unknown. 
Conclusion 
Compared to the normal population, Fontan survivors have a 4-fold higher prevalence of short stature 
and nearly 2-fold higher prevalence of abnormal BMI. Delayed puberty is common among Fontan 
survivors of both genders. More than half of the Fontan survivors (58%) had delay in one of the Tanner 
stage parameters and on an average both in males and females, there was a delay of 1.5-2 years in 
achievement of earlier Tanner stages compared to the normal population.  Abnormal anthropometry, but 
not delayed puberty, was associated with lower overall QoL and perceived physical appearance scores. 
Routine screening for abnormal anthropometry, especially in HLHS and in lower socioeconomic status 
families, should be considered to allow for interventions that might ameliorate the negative psychosocial 
impact.   
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Figure 1: Shown in this forest plot are the mean differences in years between the Fontan study cohort 
and the normal population (NHANES III) in achieving various Tanner stages. The mean age at which the 
normal population achieves a specific Tanner stage is shown in the last column. 
Figure 2: Box and whisker plot in panel A and B depict the total generic QoL scores for subjects with 
normal versus abnormal anthropometry stratified by 2 age groups. The dotted redline indicates the mean 
score for normal children in the same age group. Panel C shows the total generic QoL scores for normal 
subjects versus those with delayed puberty for the entire study cohort. Panel D depicts the difference in 
perceived physical appearance score (cardiac module) for subjects with normal versus abnormal 
anthropometry. * represent statistically significant difference with p value <0.05. 
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Females 125 (42%) 
Age groups (years) 
        8-12 
        13-15 
        ≥16 
41% 
33% 
26% 
Race 
        White 
        Black 
        Others 
Ethinicity 
        Hispanic 
        Non-Hispanic 
                                                                                              
224 (75%) 
35 (12%) 
40 (13%)  
 
43 (14%) 
255 (86%) 
Hypoplastic left heart syndrome N (%) 98 (33%) 
Heterotaxy N (%) 24 (8%) 
Ventricular morphology  
Left ventricle dominant  152(50%) 
Right ventricle dominant 136 (46%) 
Mixed ventricular morphology 11 (4%) 
Median age at enrollment (years) (IQR) 13.9 (11.3, 16.1) 
Median age at Fontan (years) (IQR) 3 (2,4) 
Median age at Glenn (months) (IQR) 4 (3,5) 
Median weight at Fontan in Kg (IQR) 13.7 (11.9, 15.3) 
Mean height at Fontan in cm (SD) 93.3 (±15.2) 
Median number of surgeries before Fontan (range) 2 (1-3) 
>2 cardiac surgeries 96 (32%) 
Type of Fontan   
Extra/intra-cardiac conduit 199 (67%) 
Lateral tunnel  85(29%) 
Hemi-Fontan  56 (19%) 
Kawashima  6 (2%) 
Other Fontan type  9 (4%) 
Post-Fontan Complications  
Pacemaker  45 (15%) 
Stroke 33 (11%) 
PLE  15 (5%) 
Cirrhosis  3 (1%) 
Arrhythmia 39 (13%) 
Thrombosis 20 (7%) 
Seizure 10 (3%) 
Severity of ventricular dysfunction  (N=270)  
Mild 17 (6%) 
Moderate 5 (2%) 
Severe 7 (2%) 
Severity of AV valve regurgitation (N=268)  
Mild  118 (39%) 
Moderate 34 (11%) 
Severe 3 (1%) 
NYHA grade 3 and 4 30 (10%) 
% Predicted Peak VO2 max (N=102) 67.5±15.4 
B-Natiuretic Peptide (BNP) pg/ml (N=39) 29.1 (15.9, 139.2) 
Pulmonary vasodilators 15 (5%) 
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ACE inhibitors 156 (52%) 
Beta blockers 34 (11%) 
Diuretics 48 (16%) 
Mean age at menarche in years (SD) (N=76) 12.5 (±1.7) 
Mean Height Z-score  -0.7 (±1.6) 
BMI Z-score -.01 (±1.9) 
PLE: protein losing enteropathy; AV: atrioventricular; NYHA: New York Heart Association; ACE: 
Angiotensin converting enzyme; BMI: Body mass index. For missing values, we have added number of 
subjects in column 1. 
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tTable 2: Results of multivariable mixed effect regression analysis accounting for clustering showing factors associated with abnormal anthropometry, delayed puberty and QoL scores. 
 
 Adjusted OR 95% CI P-Value 
Factors associated with abnormal anthropometry 
[AIC=115.3] 
    
NYHA grade 3 and 4 vs. lower 10.9 1.8 124.3 0.046 
Oxygen consumption  0.9 0.88 0.98 0.04 
Factors associated with delayed puberty 
[AIC=230.5] 
    
Cardiac surgeries before Fontan >2 vs ≤2 2.98 1.45 6.5 0.02 
Factors associated with PedsQL scores Estimate 95% CI P-Value 
Self-report (total score) [R
2
= 0.132]     
Abnormal anthropometry -7.4 -11.3 -3.6 <0.001 
Family income < $25,000 (ref:  ≥$75,000) -9.1 -16.4 -1.7 .01 
HLHS vs. others -4.5 -8.3 -0.6 .02 
Proxy report (total score) [R
2
= 0.157]     
Abnormal anthropometry -9.2 -13.5 -4.9 <0.001 
Family income < $25,000  -10.0 -18.3 -1.8 .01 
HLHS vs. others -4.2 -8.5 .03 .05 
Self-report (cardiac domain 3:physical 
appearance) [R
2
= 0.079] 
    
Male vs. female 8.2 2.2 14.2 0.007 
Abnormal anthropometry -5.3 -11.5 0.98 0.1 
Family income $25,000 - $49,999  -11.2 -21.5 -0.98 0.03 
Family income < $25,000  -12.4 -24.4 -0.3 0.04 
Proxy report (cardiac domain 3:physical 
appearance) [R
2
=0.138] 
    
Abnormal anthropometry -12.6 -18.8 -6.4 < 0.001 
Family income- $50,000 - 74,999 -16.5 -26.5 -6.4 0.001 
Family income- $25,000 - $74,999 -14.2 -24.6 -3.8 0.007 
Family income < $25,000  -19.4 -31.6 -7.2 0.002 
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Figure 1: Shown in this forest plot are the mean differences in years between the Fontan study cohort and 
the normal population (NHANES III) in achieving various Tanner stages. The mean age at which the normal 
population achieves a specific Tanner stage is shown in the last column.  
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Figure 2: Box and whisker plot in panel A and B depict the total generic QoL scores for subjects with normal 
versus abnormal anthropometry stratified by 2 age groups. The dotted redline indicates the mean score for 
normal children in the same age group. Panel C shows the total generic QoL scores for normal subjects 
versus those with delayed puberty for the entire study cohort. Panel D depicts the difference in perceived 
physical appearance score (cardiac module) for subjects with normal versus abnormal anthropometry. * 
represent statistically significant difference with p value <0.05.  
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